No photo of Maria K Hordinsky
Contact Expert

View Scopus Profile

Maria K Hordinsky

1982 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Projects

Filter
Active
Active

A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY ANDSAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSIONPERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 ANDPF-067008

Hordinsky, M. K.

PFIZER, INC.

6/20/19 → 6/30/24

Project: Research project

A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

Hordinsky, M. K.

PFIZER, INC.

6/17/19 → 6/30/24

Project: Research project

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)

Hordinsky, M. K.

ACLARIS THERAPEUTICS, INC

1/4/19 → 1/31/24

Project: Research project

A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

Hordinsky, M. K.

PFIZER, INC.

10/9/18 → 10/30/23

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Hordinsky, M. K.

Eli Lilly and Company

8/6/18 → 8/30/23

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

Hordinsky, M. K.

ACLARIS THERAPEUTICS, INC

6/15/18 → 6/30/22

Project: Research project

A Randomized, Double-blind, Vehicle-controlled

Hordinsky, M. K.

ACLARIS THERAPEUTICS, INC

8/1/17 → 8/30/21

Project: Research project

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

Hordinsky, M. K.

PFIZER, INC.

6/21/17 → 1/30/22

Project: Research project

Multicenter, Randomized, Double-Blind Placebo-Controlled

Hordinsky, M. K.

Allergan, Inc.

3/1/16 → 3/30/21

Project: Research project

Mechanism of immune modulation by DPCP in alopecia

Hordinsky, M. K.

NATIONAL ALOPECIA AREATA FOUNDATION

1/1/16 → 12/31/21

Project: Research project

Skin Dendritic Cells and Humoral Immunity

Jenkins, M. & Hordinsky, M. K.

University of Pittsburgh

9/1/15 → 3/31/20

Project: Research project

An Open-Label (Part A) and a Double-Blind, Randomized, P

Hordinsky, M. K.

Incyte Corporation

8/1/15 → 8/30/20

Project: Research project

A Randomized, Double-Blind Clinical Trial to Evaluate th

Hordinsky, M. K.

Lexington International, LLC

11/17/09 → 12/31/20

Project: Research project

APPLES: A prospective, pediatric, longitudinal evaluatio

Hordinsky, M. K.

Astellas Pharma US, Inc.

5/17/05 → 3/31/20

Project: Research project